Meeting
2022 ASCO Annual Meeting
Mode of detection of second breast cancers in patients undergoing surveillance after treatment of ductal carcinoma in situ.
Authors
Bethany Waites
Department of Obstetrics and Gynecology, Kaiser Permanente San Francisco, San Francisco, CA
Bethany Waites , Liisa Lyon , Gillian Kuehner , Patience Odele , Laurel A. Habel , Aida Shirazi , Raymond Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Local-Regional Therapy
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 571)
DOI
10.1200/JCO.2022.40.16_suppl.571
Abstract #
571
Poster Bd #
343
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ breast cancer from 2001-2016.
First Author: Erin Aiello Bowles
Poster
2021 ASCO Annual Meeting
Disparities in surveillance imaging after breast conserving surgery for primary DCIS.
First Author: Danalyn Byng
Poster
2017 ASCO Annual Meeting
Prospective study of magnetic resonance imaging (MRI) and multiparameter gene expression assay in ductal carcinoma in situ (DCIS): A trial of the ECOG-ACRIN cancer research group (E4112).
First Author: Seema Ahsan Khan
Poster
2014 ASCO Annual Meeting
Clinical utility of the 12-gene DCIS score assay: Impact on treatment (Tx) recommendations.
First Author: Michael Alvarado